Immutable evidence record · ticker
Alnylam Pharmaceuticals, Inc. (A1LN34)
Published as observed on 18 August 2026 at 14:48 BST.
Alnylam Pharmaceuticals, Inc. has a negative company news read. Its latest completed weekly trend is negative.
- As of
- 18 Aug 2026, 14:48
- Scope
- company and instrument
- Evidence
- 21 items
- Independent sources
- 3
- Country
- Brazil
- Sector
- Healthcare
- Previous read
- 50.000
- Change
- -7.000
Verification
Evidence & related research
Company chart →Technicals & Market Dynamics →Technical Research Pack →Company news sentiment →Current financial news →
This is dated market research. Coverage may be delayed, incomplete or unavailable.
Cite this record:
Sharemaestro, Alnylam Pharmaceuticals, Inc. (A1LN34), 2026-08-18, https://sharemaestro.com/evidence/750c8c53-18ab-43eb-8316-9f5c00a6e5c2/
Record checksum 07f11698e3915b7c8b116f78762292318b9cde4e4e69b44aef7c66137083698d
